Olema Oncology Company

Olema Oncology is a preclinical biotechnology company that develops new drugs for the treatment and prevention of breast cancer.
Industry: General Healthcare
Headquarters: San Francisco, California, United States
Founded Date: 01-01-2007
Employees Number: 11-50
Funding Status: IPO
Investors Number: 15
Total Funding: $145,054,922
Estimated Revenue: $1M to $10M
Last Funding Date: 2020-10-01
Last Funding Type: Series C

Visit Website
Register and Claim Ownership